United States · FDA National Drug Code directory
Mifepristone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76346-654_4b30c5df-70a3-418c-b2f4-26ab504eb0a3
- Product NDC
- 76346-654
- Form
- TABLET
- Composition / generic term
- Mifepristone
- Labeler
- Corcept Therapeutics Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240528
- Source listing expiry
- 20261231
Source-listed ingredients
- MIFEPRISTONE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 280 TABLET in 1 BOTTLE (76346-654-03) · 76346-654-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →